{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T08:04:54Z","timestamp":1777363494410,"version":"3.51.4"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T00:00:00Z","timestamp":1765238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T00:00:00Z","timestamp":1765238400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s00259-025-07645-w","type":"journal-article","created":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T05:04:07Z","timestamp":1765256647000},"page":"3042-3055","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Istanbul PSMA PET\/CT criteria (IPPC): an imaging-based approach to patient selection for active surveillance"],"prefix":"10.1007","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4050-1972","authenticated-orcid":false,"given":"Levent","family":"Kabasakal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7706-6388","authenticated-orcid":false,"given":"Kaan","family":"Ak\u00e7ay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3738-6491","authenticated-orcid":false,"given":"Alan Nalan","family":"Sel\u00e7uk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7187-7203","authenticated-orcid":false,"given":"Gamze","family":"Beyda\u011f\u0131","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5625-9749","authenticated-orcid":false,"given":"Elife","family":"Akg\u00fcn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9373-8693","authenticated-orcid":false,"given":"Re\u015fit","family":"Akyel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5399-9394","authenticated-orcid":false,"given":"T\u00fcrkay","family":"Toklu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7837-9861","authenticated-orcid":false,"given":"R\u00fc\u015ft\u00fc","family":"T\u00fcrkay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1169-870X","authenticated-orcid":false,"given":"Saadettin","family":"Eski\u00e7orap\u00e7\u0131","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6623-1600","authenticated-orcid":false,"given":"Burcu Esen","family":"Akka\u015f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3650-8258","authenticated-orcid":false,"given":"Umut","family":"Elbo\u011fa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8168-136X","authenticated-orcid":false,"given":"Halil","family":"K\u00f6mek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9142-8752","authenticated-orcid":false,"given":"Elif \u00c7\u0131ng\u0131","family":"\u00d6zdemir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2330-8078","authenticated-orcid":false,"given":"Onur Erdem","family":"\u015eahin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3488-0571","authenticated-orcid":false,"given":"Ali R\u0131za","family":"Kural","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,9]]},"reference":[{"issue":"2","key":"7645_CR1","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.eururo.2024.03.027","volume":"86","author":"P Cornford","year":"2024","unstructured":"Cornford P, van den Bergh RCN, Briers E, Van den Broeck T, Brunckhorst O, Darraugh J, Eberli D, De Meerleer G, et al. EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate Cancer-2024 Update. Part I: Screening, Diagnosis, and local treatment with curative intent. Eur Urol. 2024;86(2):148\u201363. Epub 2024 Apr 13. PMID: 38614820.","journal-title":"Eur Urol"},{"issue":"5","key":"7645_CR2","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1007\/s00259-023-06556-y","volume":"51","author":"K Akcay","year":"2024","unstructured":"Akcay K, Kibar A, Sahin OE, Demirbilek M, Beydagi G, Asa S, Aghazada F, Toklu T, et al. Prediction of clinically significant prostate cancer by [68 Ga]Ga-PSMA-11 PET\/CT: a potential tool for selecting patients for active surveillance. Eur J Nucl Med Mol Imaging. 2024;51(5):1467\u201375. https:\/\/doi.org\/10.1007\/s00259-023-06556-y. Epub 2023 Dec 19. PMID: 38112777.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"7645_CR3","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/j.eururo.2016.06.007","volume":"70","author":"LP Bokhorst","year":"2016","unstructured":"Bokhorst LP, Valdagni R, Rannikko A, Kakehi Y, Pickles T, Bangma CH, Roobol MJ, PRIAS study group. A decade of active surveillance in the PRIAS study: an update and evaluation of the criteria used to recommend a switch to active treatment. Eur Urol. 2016;70(6):954\u201360. Epub 2016 Jun 19. PMID: 27329565.","journal-title":"Eur Urol"},{"key":"7645_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2018.00623","volume":"8","author":"MC Hupe","year":"2018","unstructured":"Hupe MC, Philippi C, Roth D, K\u00fcmpers C, Ribbat-Idel J, Becker F, et al. Expression of prostate-specific membrane antigen (PSMA) on biopsies is an independent risk stratifier of prostate cancer patients at time of initial diagnosis. Front Oncol. 2018;8:623. https:\/\/doi.org\/10.3389\/fonc.2018.00623.","journal-title":"Front Oncol"},{"issue":"1","key":"7645_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-22594-1","volume":"8","author":"S Bravaccini","year":"2018","unstructured":"Bravaccini S, Puccetti M, Bocchini M, Ravaioli S, Celli M, Scarpi E, et al. PSMA expression: a potential ally for the pathologist in prostate cancer diagnosis. Sci Rep. 2018;8(1):4254. https:\/\/doi.org\/10.1038\/s41598-018-22594-1.","journal-title":"Sci Rep"},{"issue":"1","key":"7645_CR6","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1097\/MNM.0000000000000942","volume":"40","author":"E Demirci","year":"2019","unstructured":"Demirci E, Kabasakal L, \u015eahin OE, Akg\u00fcn E, G\u00fcltekin MH, Do\u011fanca T, Tuna MB, \u00d6bek C, et al. Can SUVmax values of Ga-68-PSMA PET\/CT scan predict the clinically significant prostate cancer? Nucl Med Commun. 2019;40(1):86\u201391. PMID: 30395048; PMCID: PMC6282663.","journal-title":"Nucl Med Commun"},{"issue":"6","key":"7645_CR7","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.eururo.2021.08.002","volume":"80","author":"L Emmett","year":"2021","unstructured":"Emmett L, Buteau J, Papa N, Moon D, Thompson J, Roberts MJ, Rasiah K, Pattison DA, et al. The additive diagnostic value of prostate-specific membrane antigen positron emission tomography computed tomography to multiparametric magnetic resonance imaging triage in the diagnosis of prostate cancer (PRIMARY): A prospective multicentre study. Eur Urol. 2021;80(6):682\u20139. Epub 2021 Aug 28. PMID: 34465492.","journal-title":"Eur Urol"},{"issue":"11","key":"7645_CR8","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.2967\/jnumed.121.263448","volume":"63","author":"L Emmett","year":"2022","unstructured":"Emmett L, Papa N, Buteau J, Ho B, Liu V, Roberts M, Thompson J, Moon D. The PRIMARY score: using intraprostatic 68Ga-PSMA PET\/CT patterns to optimize prostate cancer diagnosis. J Nucl Med. 2022;63(11):1644\u201350. https:\/\/doi.org\/10.2967\/jnumed.121.263448. Epub 2022 Mar 17. PMID: 35301240; PMCID: PMC9635676.","journal-title":"J Nucl Med"},{"issue":"5","key":"7645_CR9","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1007\/s00259-024-06642-9","volume":"51","author":"L Kabasakal","year":"2024","unstructured":"Kabasakal L, Turkay R, Onal B. Incorporating the [68Ga]Ga-PSMA PET\/CT PRIMARY score into the selection criteria for prostate cancer patients eligible for active surveillance. Eur J Nucl Med Mol Imaging. 2024;51(5):1464\u20136. https:\/\/doi.org\/10.1007\/s00259-024-06642-9.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7645_CR10","doi-asserted-by":"publisher","unstructured":"Emmett L, Papa N, Hope TA, Fendler W, Calais J, Burger I, Eiber M, Barbato F, et al. Tomography\/Computed Tomography PRIMARY Score in a Composite (P) Score for More Accurate Diagnosis of Clinically Significant Prostate Cancer. J Urol. 2024;212(2):299\u2013309. https:\/\/doi.org\/10.1097\/JU.0000000000004010. Epub 2024 May 17. PMID: 38758680. Beyond Prostate Imaging Reporting and Data System: Combining Magnetic Resonance Imaging Prostate Imaging Reporting and Data System and Prostate-Specific Membrane Antigen-Positron Emission.","DOI":"10.1097\/JU.0000000000004010"},{"issue":"11","key":"7645_CR11","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1097\/MNM.0000000000000566","volume":"37","author":"E Demirci","year":"2016","unstructured":"Demirci E, Sahin OE, Ocak M, Akovali B, Nematyazar J, Kabasakal L. Normal distribution pattern and physiological variants of 68Ga-PSMA-11 PET\/CT imaging. Nucl Med Commun. 2016;37(11):1169\u201379. https:\/\/doi.org\/10.1097\/MNM.0000000000000566.","journal-title":"Nucl Med Commun"},{"issue":"1","key":"7645_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4274\/mirt.galenos.2025.16023","volume":"34","author":"K Ak\u00e7ay","year":"2025","unstructured":"Ak\u00e7ay K, Beyda\u011f\u0131 G, \u015eahin OE, Akyel R, Akg\u00fcn E, Ekmek\u00e7io\u011flu \u00d6, Alan Sel\u00e7uk N, Toklu T, et al. Improved accuracy and reliability of PRIMARY scoring using delayed [68Ga] Ga-PSMA PET\/CT imaging. Mol Imaging Radionucl Ther. 2025;34(1):1\u20139. https:\/\/doi.org\/10.4274\/mirt.galenos.2025.16023. PMID: 39917984; PMCID: PMC11827525.","journal-title":"Mol Imaging Radionucl Ther"},{"issue":"3","key":"7645_CR13","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.euo.2023.11.008","volume":"7","author":"JP Buteau","year":"2024","unstructured":"Buteau JP, Moon D, Fahey MT, Roberts MJ, Thompson J, Murphy DG, Papa N, Mitchell C, et al. Clinical trial protocol for PRIMARY2: A Multicentre, phase 3, randomised controlled trial investigating the additive diagnostic value of [68Ga]Ga-PSMA-11 positron emission tomography\/Computed tomography in men with negative or equivocal multiparametric magnetic resonance imaging for the diagnosis of clinically significant prostate cancer. Eur Urol Oncol. 2024;7(3):544\u201352. Epub 2023 Dec 6. PMID: 38061976.","journal-title":"Eur Urol Oncol"},{"issue":"14","key":"7645_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics15141779","volume":"15","author":"G Mutevelizade","year":"2025","unstructured":"Mutevelizade G, Bozdemir BC, Aydin N, Sayit E. An innovative approach with [68Ga]Ga-PSMA PET\/CT: the relationship between PRIMARY scores and clinical and histopathological findings. Diagnostics. 2025;15(14):1779. https:\/\/doi.org\/10.3390\/diagnostics15141779.","journal-title":"Diagnostics"},{"issue":"5","key":"7645_CR15","doi-asserted-by":"publisher","first-page":"750","DOI":"10.2967\/jnumed.116.183483","volume":"58","author":"A Afshar-Oromieh","year":"2017","unstructured":"Afshar-Oromieh A, Sattler LP, Mier W, Hadaschik BA, Debus J, Holland-Letz T, et al. The clinical impact of additional late PET\/CT imaging with 68Ga-PSMA-11 (HBED-CC) in the diagnosis of prostate cancer. J Nucl Med. 2017;58(5):750\u20135. https:\/\/doi.org\/10.2967\/jnumed.116.183483.","journal-title":"J Nucl Med"},{"issue":"3","key":"7645_CR16","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1111\/bju.15664","volume":"129","author":"H Veerman","year":"2022","unstructured":"Veerman H, Donswijk M, Bekers E, Olde Heuvel J, Bodar YJL, Boellaard TN, et al. The clinical characteristics of patients with primary non-prostate-specific membrane antigen-expressing prostate cancer on preoperative positron emission tomography\/computed tomography. BJU Int. 2022;129(3):314\u20137. https:\/\/doi.org\/10.1111\/bju.15664.","journal-title":"BJU Int"},{"issue":"470","key":"7645_CR17","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aag3326","volume":"10","author":"LA Caromile","year":"2017","unstructured":"Caromile LA, Dortche K, Rahman MM, Grant CL, Stoddard C, Ferrer FA, et al. PSMA redirects cell survival signaling from the MAPK to the PI3K-AKT pathways to promote the progression of prostate cancer. Sci Signal. 2017;10(470):eaag3326. https:\/\/doi.org\/10.1126\/scisignal.aag3326.","journal-title":"Sci Signal"},{"issue":"2","key":"7645_CR18","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.eururo.2021.11.019","volume":"82","author":"VH Meissner","year":"2021","unstructured":"Meissner VH, Rauscher I, Schwamborn K, Neumann J, Miller G, Weber W, Gschwend JE, Eiber M, Heck MM. Radical prostatectomy without prior biopsy following multiparametric magnetic resonance imaging and Prostate-specific membrane antigen positron emission tomography. Eur Urol. Aug; 2021;82(2):156\u201360. Epub 2021 Dec 6. PMID: 34887117.","journal-title":"Eur Urol"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-025-07645-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-025-07645-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-025-07645-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T01:26:05Z","timestamp":1774401965000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-025-07645-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,9]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["7645"],"URL":"https:\/\/doi.org\/10.1007\/s00259-025-07645-w","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,9]]},"assertion":[{"value":"11 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There is not any patient\u2019s personal data in this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"Written consent was obtained from all patients\n                      .","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The study was approved by institutional review board and it was conducted in accordance with the Declaration of Helsinki.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"\u201cThe authors have no relevant financial or non-financial interests to disclose.\u201d","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}